In autoimmune diseases, large expansions in IgD− IgM+ CD27+ and IgG− CD27+ phenotypes, which dominantly employ IgG1 and IgG3, the powerful activators of complement and are implicated in target destruction by ADCC (Berkowska et al., 2011). Here, CD27 is linked to autoimmune disease.